Interactive Discussions

Interactive Discussions are informal, moderated discussions, allowing participants to exchange ideas and experiences and develop future collaborations around a focused topic. Each discussion will be led by a facilitator who keeps the discussion on track and the group engaged. For in-person events, the facilitator will lead from the front of the room while attendees remain seated to promote social distancing. For virtual attendees, the format will be in a Zoom room. To get the most out of this format, please come prepared to share examples from your work, be a part of a collective, problem-solving session, and participate in active idea sharing.

This year’s Interactive Discussions will take place on Tuesday, September 28, 4:40 - 5:25 pm EDT and Thursday, September 30, 9:30 - 10:15 am EDT. Below are last year's topics. Please revisit this page in July for 2021 content updates.


2020 Topics:

  • How Can Chemoproteomics Technologies and Assays be Exploited for Target ID and Validation?
  • Using Diverse Modalities to Effectively Target RNA
  • Characterization of Antibodies Against Membrane Proteins
  • Drug Development Challenges for NASH Therapies
  • Translational Strategies in CNS Drug Development
  • iPSC Disease Modelling
  • Role of Structural Biology and Molecular Modeling during Drug Lead Generation
  • What Are Some of the Challenges in Bringing Protein-Degrader Drugs to the Clinic?
  • Structural and Biophysical Tools for GPCRs
  • New Fibrosis Targets & Establishing Proof of Concept
  • Preclinical Strategies for T Cell Therapy
  • Imaging in Drug Target Research and Preclinical Studies
  • Integrated Biomarker Approaches
  • Advances in Structural Biology for Drug Discovery and Development